®
X
GALA
CONFERENCE
®
WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT
•
M
E
N
U
•
news
November 13, 2015
Bloom Burton’s analyst David Martin speaks to BNN about Concordia's sell-off and the future of biotech in Canada
Click on the image to view the full video.
RELATED NEWS
See All News
COSCIENS Acquires Nualtis Corp.
Conavi Medical Corp. Announces Closing of $10M Public Offering
SteriMax Announces Acquisition of Andone Pharmaceuticals, Expanding Presence in Medical Device and Veterinary Markets
Helus Pharma™ Announces US$50 Million Underwritten Offering
Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full
PharmaEssentia Expands North American Commercial Footprint with Acquisition of Canadian Partner FORUS Therapeutics
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs
Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc.
Three Finalists Announced for the 2026 Bloom Burton Award
Click on the image to view the full video.
